In the treatment of advanced hormone-resistant prostate cancer, the ai
m is an improvement in quality of life since treatment strategies are
merely palliative and life cannot be prolonged. Therapy is based on me
dical pain relief for different aspects of pain without seriously affe
cting activity and quality of life. With respect to therapy of chronic
pain, Germany can be regarded as a developing country. It is definite
ly in the interest of urological cancer patients that this situation w
ill be finished.